In exploratory human trials—for instance, a high-dose CBD study in people with a cocaine use disorder—high systemic exposure was linked with reductions in IL-6 and VEGF-A and shifts in immune cell subsets, notwithstanding heterogeneity in plasma concentrations and sensitivity to analytical choices [6]. Here, IL6 is linked to cocaine use disorder.